EUVIMEDEUVIMED entdecken
Open Access

ImmunoPET Imaging of Trop2 Expression in Bladder Cancer Using [ 64 Cu]Cu-NOTA-Trodelvy

Wenpeng Huang, Tianyao Wang, Fangfang Chao, Qi Yang, Jason C Mixdorf, Liming Li, Jonathan W Engle iD, Yu Fan, Lei Kang iD, Weibo Cai iD

Molecular Pharmaceutics · 07.04.2025 · 22 (4) · 2266-2275

DOI: 10.1021/acs.molpharmaceut.5c00069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 10.03.2025. Verfasst von Wenpeng Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Antigens, Neoplasm, Copper Radioisotopes, Cell Adhesion Molecules. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, Peking University First Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trop2 exhibits significantly elevated expression in numerous solid malignancies, playing a crucial role in tumor advancement, whereas its presence in healthy tissues is minimal. In this study, we investigated Trop2 expression in bladder cancer models using [64Cu]Cu-NOTA-Trodelvy for immunoPET imaging. In HT-1376 models, [64Cu]Cu-NOTA-Trodelvy effectively visualized tumor as early as 12 h p.i. (10.30 ± 1.45% ID/g), with tumor uptake increasing and peaking at 48 h p.i. (13.73 ± 1.16% ID/g), highlighting its potential for tumor imaging. Control groups also demonstrated low tumor uptake (5.27 ± 1.14% ID/g at 48 h in the blocking group; 6.33 ± 0.74% ID/g at 48 h in UM-UC-3; 4.50 ± 0.30% ID/g at 48 h in the [64Cu]Cu-NOTA-IgG group). Long-term fluorescence imaging further confirmed the tumor uptake rate in the IRDye 800CW-Trodelvy group was significantly higher than in the IRDye 800CW-Trodelvy blockade group (P < 0.001). Our findings demonstrated that [64Cu]Cu-NOTA-Trodelvy enables specific and prolonged tumor accumulation in bladder cancer models, providing precise and noninvasive monitoring of Trop2 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsAntigens, NeoplasmCopper RadioisotopesCell Adhesion MoleculesPositron-Emission TomographyHumansAnimalsMiceCell Line, TumorHeterocyclic Compounds, 1-RingFemaleTissue DistributionRadiopharmaceuticals

Stichwörter der Autor:innen

Cu-64ImmunoPETTrop2antibody-drug conjugatebladder cancerradioactive tracer

Substanzen

Antigens, NeoplasmCopper RadioisotopesCell Adhesion MoleculesTACSTD2 protein, humanHeterocyclic Compounds, 1-Ring1,4,7-triazacyclononane-N,N',N''-triacetic acidRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
  • Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450052, China.
  • Departments of Radiology and Medical Physics, University of Wisconsin - Madison, Madison, Wisconsin 53705, United States.
  • Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450052, China.
  • Department of Urology, Peking University First Hospital, Beijing 100034, China.
  • Institute of Urology, Peking University, Beijing 100034, China.

ORCID-Profile: Jonathan W Engle, Lei Kang, Weibo Cai

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Peking University First Hospital
  • China Postdoctoral Science Foundation
  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
  • National Natural Science Foundation of China
  • Beijing Nova Program
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Huang, W., Wang, T., Chao, F., Yang, Q., Mixdorf, J. C., Li, L., Engle, J. W., Fan, Y., Kang, L., & Cai, W. (2025). ImmunoPET Imaging of Trop2 Expression in Bladder Cancer Using [ 64 Cu]Cu-NOTA-Trodelvy. Molecular Pharmaceutics, 22(4), 2266-2275. https://doi.org/10.1021/acs.molpharmaceut.5c00069

Vancouver

Huang W, Wang T, Chao F, Yang Q, Mixdorf JC, Li L, et al. ImmunoPET Imaging of Trop2 Expression in Bladder Cancer Using [ 64 Cu]Cu-NOTA-Trodelvy. Molecular Pharmaceutics. 2025;22(4):2266-2275. doi:10.1021/acs.molpharmaceut.5c00069

BibTeX
@article{Huang2025,
  author = {Huang, Wenpeng and Wang, Tianyao and Chao, Fangfang and Yang, Qi and Mixdorf, Jason C and Li, Liming and Engle, Jonathan W and Fan, Yu and Kang, Lei and Cai, Weibo},
  title = {ImmunoPET Imaging of Trop2 Expression in Bladder Cancer Using [ 64 Cu]Cu-NOTA-Trodelvy},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {4},
  pages = {2266--2275},
  doi = {10.1021/acs.molpharmaceut.5c00069}
}
Kostenlos starten →